Valneva Vaccine Results Published :Clinical Infection Research Group

The Lancet has published the results from the Valneva COVID-19 vaccine clinical trial. The paper, linked below, discusses how the Valneva vaccine (VLA2001) showed superior immunogenicity compared to the Oxford ChAdOx1 vaccine.

The vaccine is now licensed in the UK, EU, UAE, and Bahrain and endorsed by WHO as a result of this study.

The link to the paper is HERE

Privacy Overview

This website uses 'essential' cookies, along with third-party cookies that help us to understand how you use this website. You have the option to opt-out of using these 'non-essential' cookies. For more information, see our Privacy Policy.

Necessary

Always Enabled

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_211871509_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Valneva Vaccine Results Published

The results from the Valneva vaccine trial have been published in The Lancet! Dr. Iain Page is mentioned as one of the Valneva phase 3 trial group